#bispecific-antibodies — Thursday, July 16, 2026 (1 items)
| 0 | 💬 0 |
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-07-16 | #lymphoma #immunotherapy #clinical trial #bispecific-antibodies |